Profile data is unavailable for this security.
About the company
Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
- Revenue in AUD (TTM)2.15bn
- Net income in AUD350.40m
- Incorporated1983
- Employees4.80k
- LocationCochlear Ltd1 University AvenueMacquarie UniversitySYDNEY 2109AustraliaAUS
- Phone+61 29428-6555
- Fax+61 29428-6352
- Websitehttps://www.cochlear.com/sg/en/home
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong Weigao Group Medical Polymer Co | 2.84bn | 429.94m | 4.31bn | 12.52k | 9.90 | 0.8937 | 6.76 | 1.52 | 0.4797 | 0.4797 | 3.17 | 5.32 | 0.3945 | 2.73 | 2.06 | 1,143,574.00 | 6.15 | 7.89 | 8.23 | 10.08 | 50.21 | 55.18 | 15.58 | 18.65 | 2.13 | 13.05 | 0.148 | 25.55 | -3.77 | 8.47 | -27.57 | 6.33 | -- | -6.19 |
| iRay Technology Co Ltd | 395.45m | 121.56m | 4.34bn | 1.24k | 35.62 | 4.89 | -- | 10.98 | 5.56 | 5.56 | 18.10 | 40.53 | 0.3558 | 1.17 | 4.01 | 1,489,164.00 | 10.72 | 14.00 | 11.90 | 16.02 | 57.08 | 53.73 | 30.12 | 33.31 | 6.75 | 6.74 | 0.2717 | 29.44 | 30.47 | 34.21 | 32.49 | 63.83 | 81.84 | -- |
| ASAHI INTECC CO., LTD. | 996.58m | 155.55m | 6.42bn | 10.19k | 41.30 | 4.62 | 25.77 | 6.45 | 56.89 | 56.89 | 364.50 | 508.24 | 0.6027 | 1.20 | 5.61 | 9,718,956.00 | 9.50 | 9.57 | 11.04 | 11.20 | 64.63 | 66.78 | 15.76 | 15.93 | 2.61 | 66.60 | 0.0525 | 28.13 | 15.89 | 12.44 | 20.71 | 5.47 | 9.12 | 8.31 |
| APT Medical Inc | 354.26m | 114.62m | 6.54bn | 2.16k | 57.33 | 15.89 | -- | 18.45 | 7.94 | 7.94 | 24.54 | 28.66 | 0.6877 | 1.48 | 37.27 | 765,759.60 | 21.76 | 18.12 | 28.10 | 21.94 | 70.04 | 70.30 | 31.64 | 27.07 | 2.43 | -- | 0.0438 | 26.49 | 35.71 | 46.83 | 49.13 | 90.09 | 44.39 | -- |
| Fisher & Paykel Healthcare Corporatn Ltd | 1.56bn | 240.61m | 14.38bn | 6.56k | 59.71 | 8.88 | 43.00 | 9.23 | 0.4485 | 0.4485 | 2.90 | 3.02 | 0.7556 | 1.80 | 7.85 | 258,104.80 | 11.67 | 19.53 | 13.67 | 23.70 | 59.69 | 63.27 | 15.45 | 21.77 | 1.29 | 94.24 | 0.1558 | 46.94 | -5.98 | 10.02 | -33.59 | 5.65 | 16.44 | 13.77 |
| Cochlear Ltd | 2.15bn | 350.40m | 20.84bn | 4.80k | 59.80 | 11.69 | 47.68 | 9.70 | 5.32 | 5.32 | 32.64 | 27.23 | 0.8602 | 1.74 | 5.14 | 447,791.70 | 14.02 | 8.91 | 17.45 | 11.69 | 75.46 | 74.97 | 16.30 | 12.19 | 1.94 | 175.39 | 0.104 | 90.63 | 17.46 | 7.26 | 3.98 | 3.58 | 14.05 | 1.92 |
| Shanghai United Img Hlthcare Co Ltd | 2.32bn | 391.04m | 21.62bn | 7.30k | 55.30 | 5.60 | -- | 9.32 | 2.21 | 2.21 | 13.12 | 21.83 | 0.4658 | 1.42 | 4.66 | 1,480,689.00 | 7.91 | -- | 10.17 | -- | 49.37 | -- | 16.98 | -- | 2.76 | -- | 0.0234 | -- | 27.36 | -- | 16.86 | -- | -- | -- |
| Olympus Corp | 9.22bn | 397.27m | 26.96bn | 32.84k | 69.25 | 3.48 | 25.90 | 2.92 | 31.83 | 215.71 | 741.15 | 633.64 | 0.6405 | 1.69 | 5.42 | 27,892,220.00 | 2.79 | 6.68 | 3.75 | 9.53 | 67.08 | 65.33 | 4.35 | 9.79 | 1.58 | 12.01 | 0.2889 | 19.97 | 17.57 | 2.32 | 24.83 | 19.28 | 2.18 | 17.98 |
| Terumo Corp | 8.91bn | 996.92m | 38.96bn | 30.21k | 39.05 | 3.17 | 22.38 | 4.37 | 66.50 | 66.50 | 594.27 | 818.28 | 0.5472 | 1.69 | 5.33 | 29,303,340.00 | 6.12 | 6.43 | 7.37 | 7.51 | 51.48 | 53.00 | 11.19 | 12.47 | 1.13 | -- | 0.1569 | 28.24 | 16.62 | 6.89 | 0.5765 | -0.4353 | 11.80 | 9.86 |
| Holder | Shares | % Held |
|---|---|---|
| APG Asset Management NVas of 31 Dec 2022 | 3.20m | 4.89% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 2.18m | 3.33% |
| First Sentier Investors (Australia) IM Ltd.as of 31 Dec 2023 | 1.26m | 1.93% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 1.24m | 1.89% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.16m | 1.77% |
| Vanguard Investments Australia Ltd.as of 29 Feb 2024 | 974.00k | 1.49% |
| Walter Scott & Partners Ltd.as of 11 Apr 2024 | 591.59k | 0.90% |
| Schroder Investment Management (Singapore) Ltd.as of 31 Dec 2023 | 546.12k | 0.83% |
| Hyperion Asset Management Ltd.as of 29 Feb 2024 | 496.77k | 0.76% |
| Geode Capital Management LLCas of 11 Apr 2024 | 415.27k | 0.63% |
